Danaher Corporation (DHR) has experienced challenges in growth. The company operates in the Healthcare sector, specifically in the Diagnostics & Research industry.
Over the past 4 years, Danaher Corporation has achieved a revenue compound annual growth rate (CAGR) of 0.7%, while earnings have grown at -6.7% CAGR.
Historical revenue and profitability trends for Danaher Corporation
The chart above illustrates Danaher Corporation's revenue trajectory over the past 4 years. The revenue pattern shows the challenges the company has faced in recent periods.
Annual percentage change in revenue and earnings
Growth rates provide insight into the momentum of Danaher Corporation's business.
How efficiently Danaher Corporation converts revenue into profit
Profit margins reveal how much of each dollar of revenue Danaher Corporation retains at different stages:
Analyst estimates and forward-looking indicators
Wall Street analysts project Danaher Corporation to continue growing earnings in the coming year. The consensus analyst rating is 4.6154 based on 26 analysts.
Based on our comprehensive analysis, Danaher Corporation (DHR) demonstrates declining growth characteristics.
This growth analysis provides a comprehensive view of Danaher Corporation's historical performance and future outlook. Investors should consider these growth metrics alongside valuation, competitive positioning, and broader market conditions when making investment decisions. Past performance does not guarantee future results.
See how Danaher Corporation stacks up against similar companies
Explore growth analysis for top stocks
Related: DHR Valuation, DHR Dividend, DHR Financial Health
Compare: DHR vs AAPL, DHR vs MSFT, DHR vs GOOGL